The present invention provides a composition for treating atopic dermatitis, the composition containing, as an active ingredient, a butanol fraction of an S. fusiforme extract.

The present invention relates to compositions comprising at least about 8% -glucans and/or at least about 8% -fucans, which has a prebiotic effect and act as a replacement for in-feed antibiotics. The present invention also relates to extraction methods to obtain such extracts and various uses for the compositions comprising -glucans and/or -fucans.

The present invention relates to compositions comprising at least about 8% -glucans and/or at least about 8% -fucans, which has a prebiotic effect and act as a replacement for in-feed antibiotics. The present invention also relates to extraction methods to obtain such extracts and various uses for the compositions comprising -glucans and/or -fucans.

Compositions and methods involving administration of agents useful for the treatment, prevention, inhibition, etc., of inflammatory disease or fibrous adhesions using low sulphate fucans and, if desired, one or more other anti-inflammatory disease or anti-fibrous adhesion agent.

A composition derived or derivable from seaweed is provided. The composition comprises one or more plant hormones; and/or one or more acidic polysaccharides. Also provided is a method for producing a composition, including the step of extracting one or more agents from seaweed. A method of stimulating plant growth by applying a composition derived or derivable from seaweed is also provided.

The present disclosure relates generally to the field of anti-viral therapy and prophylaxis. Formulations and agents are provided which inhibit viruses of the Orthomyxoviridae family and ameliorate symptoms and conditions caused by viral infection. The present disclosure teaches the control of influenza virus infection and spread and amelioration of conditions caused thereby. The formulations and agents may be processed as medicaments or as health supplements for more general application such as in the form of consumer goods or consumer foods.

The present disclosure relates generally to the field of anti-viral therapy and prophylaxis. Formulations and agents are provided which inhibit viruses of the Orthomyxoviridae family and ameliorate symptoms and conditions caused by viral infection. The present disclosure teaches the control of influenza virus infection and spread and amelioration of conditions caused thereby. The formulations and agents may be processed as medicaments or as health supplements for more general application such as in the form of consumer goods or consumer foods.

The present invention relates to compositions comprising at least about 8% -glucans and/or at least about 8% -fucans, which has a prebiotic effect and act as a replacement for in-feed antibiotics. The present invention also relates to extraction methods to obtain such extracts and various uses for the compositions comprising -glucans and/or -fucans.

The present invention relates to compositions comprising at least about 8% -glucans and/or at least about 8% -fucans, which has a prebiotic effect and act as a replacement for in-feed antibiotics. The present invention also relates to extraction methods to obtain such extracts and various uses for the compositions comprising -glucans and/or -fucans.

A medicament for use in treating cardiovascular and cerebrovascular diseases, the medicament includes a marine algal glycoprotein.